Lisa Schoof

2PUBLICATIONS
6CO-AUTHORS
Information modelling, management and ontologiesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 19, 2026
Reinitiating ocrelizumab with a full 600 mg dose after extended treatment interruption: No increased risk of infusion-related reactions.

|May 08, 2026
Predictors of B-cell repopulation in people with multiple sclerosis treated with ocrelizumab: insights from two large cohorts.

Pageof 1

Frequent Collaborators

2 joint publications

Laura Hogenboom

2 joint publications

Zoé LE van Kempen

2 joint publications

Eva Mm Strijbis

1 joint publications

Antonia McLean